View Press Releases
-
Alfa Chemistry: Photochromic Materials Exhibit Intriguing Optical Properties
Earlier this month, Alfa Chemistry Materials announces the offering of photochromic materials, a material characterized by its optical properties being able to change reversibly upon irradiation. In fact, this company, reputed for the supply of all kinds of materials, has previously launched a wide array of other functional materials such as charge transfer complexes, macrocycles, phthalonitriles & naphthalonitriles, pressure & heat sensitive recording materials, semiconducting materials, silane coupling agents, and UV absorbents.
May 8, 2022
-
How to Optimize Fermentation Process? Learn from the Workflows of BOC Sciences
BOC Sciences divides the whole fermentation optimization process into two sections: upstream and downstream process optimization.
May 5, 2022
-
A Collection of Current In-Demand COVID-19 Related Products
BOC Sciences offers several related products that show great benefits to the anti-epidemic activities.
May 5, 2022
-
What Amino Acid Related Services Are Available at BOC Sciences?
Several golden services of BOC Sciences regarding amino acid synthesis, labeling, and analysis will be introduced to guide researchers through finding out their desired assistance.
May 5, 2022
-
Vital PseudoUridine and Derivatives That mRNA Vaccine Researchers Should Know
BOC Sciences proudly announces to become the largest pseudoUridine supplier in the world.
May 5, 2022
-
A Brief Guide to Identify a Reliable Supplier of Phosphoramidites
Synthetic DNA/RNA is an important technique in therapeutic DNA/RNA research, which is the undisputed truth in the pharma industry. However, if you interview a certain number of researchers specializing in DNA/RNA related fields, they would give the feedback that looking for the desired DNA/RNA synthesis materials and identifying a supplier worthy of long-term cooperation would be one of the toughest tasks.
Apr 30, 2022
-
Alfa Chemistry: Polymer Surfactants Have Exceptional Properties
With broad use in the manufacture of cleaning, pharmaceutical, cosmetic, and food products, the significance of polymer surfactants can never be neglected. In a recent statement, Alfa Chemistry announced the supply of a wide range of polymer surfactants for potential uses in both scientific research and industrial manufacturing.
May 4, 2022
-
CD Formulation Newly Launches Drug Packaging Services for the Pharmaceutical Industry
Packaging is another factor that decides the stability and integrity of drugs. Except for the role as an excipient producer and supplier, the US-based CRO company CD Formulation today announces that it newly launches a wide range of pharmaceutical packaging services, providing support throughout the whole process of packaging design, from material selection to chemical and surface analysis and to design selection.
May 4, 2022
-
AVIA Names Daniel Clark Senior Vice President, Center for Care Transformation; Will Drive Digital Care Transformation Initiatives for Health Systems
Seasoned Clinical and Digital Executive Joins Leading Digital Transformation Company to Meet Demand for Digitally Enabled Care Models
May 4, 2022
-
2bPrecise Named “Best Overall Genomics Company” in 2022 MedTech Breakthrough Awards Program
-
Kyruus ProviderMatchⓇ Wins MedTech Breakthrough Award for Best Patient Scheduling Solution for Third Year in Row
Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies
May 4, 2022
-
Egle Therapeutics appoints Pierre Legault as Chairman and Board Member
Egle Therapeutics SAS (Egle), an emerging biotechnology company dedicated to developing novel immunotherapies for oncology and autoimmune diseases, is pleased to announce Pierre Legault as Chairman and board member as of March 2022.
May 4, 2022
-
Paradigm4 launches REVEAL: Proteomics to transform protein bio-markers research!
Paradigm4 has today unveiled REVEAL: Proteomics, the newest use case specific app powered by the Paradigm4 FLASH high-performance bioinformatics platform.
May 3, 2022
-
Rousselot® Biomedical announces the launch of Quali-Pure HGP 2000
Rousselot®, Darling Ingredients’ health brand and the global leader of collagen-based solutions1, launches Quali-Pure™ HGP 2000, a new endotoxin-controlled, pharmaceutical-grade gelatin specifically designed for vaccines and wound healing applications. As the latest addition to Rousselot Biomedical’s rapidly expanding product offering, this new non-gelling hydrolyzed gelatin further extends the scope of biomedical applications covered by Rousselot products.
May 3, 2022
-
Watson-Marlow Fluid Technology Solutions and the National Institute for Bioprocessing Research and Training partner for biopharma training programme
Watson-Marlow Fluid Technology Solutions (WMFTS) today announces it has partnered with the National Institute of Bioprocessing Research and Training (NIBRT) to develop and deliver a combined in-person and online global biopharma training programme for employees.
May 2, 2022
-
X-Therma organ preservation technology granted FDA breakthrough device status
-
PubMed Research Workflows Made Easier with PubHive Navigator
New Google Chrome Browser extension simplifies research workflows for corporate life science teams that use PubMed and subscribe to PubHive’s cloud software platform
May 2, 2022
-
ADC Technology: A Premier Institution of Antibody-Drug Conjugates Development
ADC Technology releases a wide range of one-stop services related to ADC development such as antibody selection/modification, ADC payload and linker development, ADC conjugation, and ADC characterization and preclinical evaluation to help partners win the race of ADC research.
Apr 19, 2022
-
Benefits of Stable Isotope Labelling in Biochemistry Research
Stable isotope labeling is a powerful technique with promising applications.
Apr 28, 2022
-
PROTAC-based Methods as Traditional PROTAC Protein Degradation Technology Alternatives
Many emerging PROTAC-based technologies such as RNA-PROTACs and Photoswitchable PROTACs have expanded the scope of PROTAC development, providing more feasible potential strategies for the clinical treatment of related diseases.
Apr 28, 2022